Modulatory effect of p-chlorophenylalanine microinjected into the dorsal and median raphe nuclei on cocaine-induced behaviour in the rat

European Journal of Pharmacology

Volumn 374, Issue 3, 1999, Pages 329-340

  Herges, Sonja ^a   Taylor, David A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Behavior; Cocaine; Dorsal raphe nucleus; Median raphe nucleus; Nucleus accumbens; p Chlorophenylalanine

Indexed keywords

COCAINE; FENCLONINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG EFFECT; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MEDIAN RAPHE NUCLEUS; MODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REARING; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FENCLONINE; HEAD MOVEMENTS; MICROINJECTIONS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PERIPHERAL NERVOUS SYSTEM; RAPHE NUCLEI; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0033041433     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00333-7     Document Type: Article

References (49)

1. Aghajanian G.K., Kuhar M.J., Roth R.H. Serotonin-containing neuronal perikarya and terminals: Differential effects of p-chlorophenylalanine. Brain Res. 54:1973;85-101.
2. Bennett J.P. Jr., Snyder S.H. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol. Pharmacol. 12:1976;373-389.
3. 1 receptor agonists and p-chloroamphetamine. Synapse. 5:1990;120-133.
4. Boadle-Biber M.C., Johannessen J.N., Narasimhachari N., Phan T.-H. Activation of tryptophan hydroxylase by stimulation of central serotonergic neurons. Biochem. Pharmacol. 32(1):1983;185-188.
5. Bobillier P., Seguin S., Petitjean F., Salvert D., Touret M., Jouvet M. The raphe nuclei of the cat brain stem: a topographical atlas of their efferent projections as revealed by autoradiography. Brain Res. 113:1976;449-486.
6. Breese G.R., Cooper B.R., Mueller R.A. Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine. Br. J. Pharmacol. 52:1974;307-314.
7. Clemens J.A., Sawyer B.D., Cerimele B. Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion. Endocrinology. 100:1977;692-698.
8. Costall B., Hui S.-C.G., Naylor R.J. The importance of serotonergic mechanisms for the induction of hyperactivity by amphetamine and its antagonism by intra-accumbens (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI). Neuropharmacology. 18:1979;605-609.
9. Cunningham K.A., Lakoski J.M. Electrophysiological effects of cocaine and procaine on dorsal raphe serotonin neurons. Eur. J. Pharmacol. 148:1988;457-462.
10. Cunningham K.A., Lakoski J.M. The interaction of cocaine with serotonin dorsal raphe neurons. Neuropsychopharmacology. 3(1):1990;41-50.
11. Dourish C.T., Hutson P.H., Curzon G. para-Chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Psychopharmacology. 89:1986;467-471.
12. Fleisher L.N., Simon J.R., Aprison M.H. A biochemical-behavioral model for studying serotonergic supersensitivity in brain. J. Neurochem. 32:1979;1613-1619.
13. Geyer M.A., Puerto A., Menkes D.B., Segal D.S., Mandell A.J. Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways. Brain Res. 106:1976;257-270.
14. Guan X.-M., McBride W.J. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res. Bull. 23:1989;541-547.
15. Herges S., Taylor D.A. Depletion of serotonin in the dorsal raphe nucleus enhances cocaine-induced locomotor activity in the rat. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 4:1997;82.
16. Herges S., Taylor D.A. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat. Pharmacol. Biochem. Behav. 59:1998;595-611.
17. 1A receptors in the dorsal raphe nucleus of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 358(1):1998;R104.
18. Hervé D., Simon H., Blanc G., Lisoprawski A., Le Moal M., Glowinski J., Tassin J.P. Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat. Neurosci. Lett. 15:1979;127-133.
19. Invernizzi R., Carli M., Di Clemente A., Samanin R. Administration of 8-hydroxy-2-(di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity. J. Neurochem. 56:1991;243-247.
20. Jacobs B.L., Wise W.D., Taylor K.M. Differential behavioral and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats. Brain Res. 79:1974;353-361.
21. Jacobs B.L., Wise W.D., Taylor, Taylor K.M. Is there a catecholamine-serotonin interaction in the control of locomotor activity? Neuropharmacology. 14:1975;501-506.
22. Koe B.K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther. 199:1976;649-661.
23. Koe B.K., Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmacol. Exp. Ther. 154(3):1966;499-516.
24. Kuhn D.M., Wolf W.A., Youdim M.B.H. 5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats. Br. J. Pharmacol. 84:1985;121-129.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
26. Lucki I., Harvey J.A. Increased sensitivity to D- and L-amphetamine action after midbrain raphe lesions as measured by locomotor activity. Neuropharmacology. 18:1979;243-249.
27. Mabry P.D., Campbell B.A. Serotonergic inhibition of catecholamine-induced behavioral arousal. Brain Res. 49:1973;381-391.
28. Meek J.L., Neff N.H. Tryptophan 5-hydroxylase: approximation of half-life and rate of axonal transport. J. Neurochem. 19:1972;1519-1525.
29. Neill D.B., Grant L.D., Grossman S.P. Selective potentiation of locomotor effects of amphetamine by midbrain raphé lesions. Physiol. Behav. 9:1972;655-657.
30. Parsons L.H., Justice J.B. Jr. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606:1993;195-199.
31. Paxinos, G.P., Watson, C., 1986. The Rat Brain in Stereotaxic Co-ordinates. Academic Press, San Diego, 2nd edn.
32. Pitts D.K., Marwah J. Electrophysiological effects of cocaine on central monoaminergic neurons. Eur. J. Pharmacol. 131:1986;95-98.
33. Pitts D.K., Marwah J. Cocaine modulation of central monoaminergic neurotransmission. Pharmacol. Biochem. Behav. 26:1987;453-461.
34. Pradhan S.N., Battacharyya A.K., Pradhan S. Serotoninergic manipulation of the behavioral effects of cocaine in rats. Commun. Psychopharmacol. 2:1978;481-486.
35. Ross S.B., Renyi A.L. Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. Eur. J. Pharmacol. 7:1969;270-277.
36. Rutter J.J., Auerbach S.B. Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265(3):1993;1319-1324.
37. Scheel-Krüger, J., Braestrup, C., Nielson, M., Golembiowska, K., Mogilnicka, E., Cocaine: discussion on the role of dopamine in the biochemical mechanism of action. In: Ellinwood, E.H., Jr., Kilbey, M.M. (Eds.), Cocaine and Other Stimulants. Plenum, New York, 1977, pp. 373-407.
38. Segal D.S. Differential effects of para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy. Brain Res. 116:1976;267-276.
39. Segal M. Physiological and pharmacological evidence for a serotonergic projection to the hippocampus. Brain Res. 94:1975;115-131.
40. Shields P.J., Eccleston D. Effects of electrical stimulation of rat midbrain on 5-hydroxytryptamine synthesis as determined by a sensitive radioisotope method. J. Neurochem. 19:1972;265-272.
41. 1 receptor. Eur. J. Pharmacol. 157:1988;173-181.
42. Smith J.E., Lakoski J.M. Electrophysiological effects of fluoxetine and dloxetine in the dorsal raphe nucleus and hippocampus. Eur. J. Pharmacol. 323:1997;69-73.
43. Soubrié P., Reisine T.D., Glowinski J. Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique. Neuroscience. 13(3):1984;605-625.
44. Steigrad P., Tobler I., Waser P.G., Borbély A.A. Effect of p-chlorophenylalanine on cerebral serotonin binding, serotonin concentration and motor activity in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 305:1978;143-148.
45. Taber Pierce E., Foote W.E., Hobson J.A. The efferent connection of the nucleus raphe dorsalis. Brain Res. 107:1976;137-144.
46. Trulson M.E., Eubanks E.E., Jacobs B.L. Behavioural evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine. J. Pharmacol. Exp. Ther. 198(1):1976;23-32.
47. Wang R.Y., Aghajanian G.K. Collateral inhibition of serotonergic neurones in the rat dorsal raphe nucleus: pharmacological evidence. Neuropharmacology. 17:1978;819-825.
48. 1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem. Int. 7(6):1985;1061-1072.
49. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychological Rev. 94(4):1987;469-492.